Patents by Inventor Vicki Plaks

Vicki Plaks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Enriching Extracellular Vesicles From Biological Fluid Samples
    Publication number: 20230204588
    Abstract: The invention provides methods for enriching extracellular vesicles (EVs), including exosomes, from biological fluid samples from subjects, and optionally further testing the EVs for the presence of specific biomarkers.
    Type: Application
    Filed: October 13, 2022
    Publication date: June 29, 2023
    Applicant: Genentech Inc.
    Inventors: Christopher J. Lowe, Vicki Plaks, Jane M. Ruppel, Rebecca Suttmann
  • CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
    Publication number: 20220378830
    Abstract: The disclosure provides methods of treating a malignancy comprising administering an effective dose of an immune cell therapy (e.g., a chimeric antigen receptor genetically modified T cell immunotherapy) and methods for manufacturing such immunotherapy. Some aspects of the disclosure relate to methods of determining objective response of a patient to an immune cell immunotherapy based on the levels of patient and product attributes prior to and after administration of the immunotherapy to the patient.
    Type: Application
    Filed: May 12, 2022
    Publication date: December 1, 2022
    Inventors: Rhine Shen Garcia, Vicki Plaks
  • IMMUNOTHERAPIES
    Publication number: 20220265719
    Abstract: The disclosure relates to methods of diagnosis and prognosis, compositions for immunotherapies, methods of improving said compositions, and immunotherapies using the same (e.g., T cells, non-T cells, TCR-based therapies, CAR-based therapies, bispecific T-cell engagers (BiTEs), and/or immune checkpoint blockade).
    Type: Application
    Filed: February 18, 2022
    Publication date: August 25, 2022
    Inventors: Adrian Bot, Szu-Ting Chou, Vicki Plaks, Soumya Poddar, John Rossi
  • T CELL THERAPY
    Publication number: 20220221463
    Abstract: The disclosure relates to methods of diagnosis and prognosis, compositions for immunotherapies, methods of improving said compositions, and immunotherapies using the same
    Type: Application
    Filed: January 7, 2022
    Publication date: July 14, 2022
    Inventors: Adrian I. Bot, Justin Budka, Szu-Ting Chou, Francesca Milletti, Vicki Plaks, John M. Rossi
  • CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
    Publication number: 20220169694
    Abstract: The disclosure provides methods of treating a malignancy comprising administering an effective dose of a chimeric antigen receptor genetically modified T cell immunotherapy and methods for manufacturing such immunotherapy. Some aspects of the disclosure relate to methods of determining objective response of a patient to a T cell immunotherapy based on the levels of attributes prior to and after administration of the immunotherapy to the patient.
    Type: Application
    Filed: February 20, 2021
    Publication date: June 2, 2022
    Inventors: Adrian Bot, John Rossi, Vicki Plaks, Szu-Ting Chou, William Go, Jenny Jiyun Kim